Search by CAS No , Chemical Name or Molecular Formula
Long Term Storage
"Rivaroxaban, sold under the brand name Xarelto, among others, is an anticoagulant medication (blood thinner), which is taken by mouth. It is commonly used to prevent blood clots. It was initially developed by Bayer. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available active direct factor Xa inhibitor which is taken by mouth. The maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8\u201312 hours, but factor Xa activity does not return to normal within 24 hours, so once-daily dosing is possible.
Rivaroxaban was patented in the United States in 2007, approved for medical use in 2011, and begins to lose its patent coverage in 2020.",""
Ansell, J., et al.: Drugs, 64, 1 (2004), Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005), Kubitza, D., et al.:clin. Pharmcol. Ther., 78, 412 (2005),
We normally respond within 8 hours.
This page contains information about 5-R-Rivaroxaban Cas # 865479-71-6 and its Chiral Standards.
5-R-Rivaroxaban 5-R-Rivaroxaban Worldwide Suppliers of 5-R-Rivaroxaban https://www.clearsynth.com/en/CSO11180.html Chiral Standards Clearsynth 865479-71-6
Product rating: 9 5-R-Rivaroxaban based on 20 ratings
Keywords: Chiral Standards 5chloro-N-[[(5R)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiopheneo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2carboxamide. CS-O-11180 5-R-Rivaroxaban Rivaroxaban 865479-71-6 435.88 C19H1ClN3O5S
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945